Small-molecule modulation of p53 protein-protein interactions

2020 ◽  
Vol 401 (8) ◽  
pp. 921-931 ◽  
Author(s):  
Ave Kuusk ◽  
Helen Boyd ◽  
Hongming Chen ◽  
Christian Ottmann
Keyword(s):  
Tumor Suppressor ◽  
Small Molecules ◽  
Small Molecule ◽  
Protein Interactions ◽  
P53 Protein ◽  
Tumor Suppressor Protein ◽  
Protein Protein Interactions ◽  
Mdm2 Protein ◽  
Protein Protein Interaction ◽  
Altered Proteins

AbstractSmall-molecule modulation of protein-protein interactions (PPIs) is a very promising but also challenging area in drug discovery. The tumor suppressor protein p53 is one of the most frequently altered proteins in human cancers, making it an attractive target in oncology. 14-3-3 proteins have been shown to bind to and positively regulate p53 activity by protecting it from MDM2-dependent degradation or activating its DNA binding affinity. PPIs can be modulated by inhibiting or stabilizing specific interactions by small molecules. Whereas inhibition has been widely explored by the pharmaceutical industry and academia, the opposite strategy of stabilizing PPIs still remains relatively underexploited. This is rather interesting considering the number of natural compounds like rapamycin, forskolin and fusicoccin that exert their activity by stabilizing specific PPIs. In this review, we give an overview of 14-3-3 interactions with p53, explain isoform specific stabilization of the tumor suppressor protein, explore the approach of stabilizing the 14-3-3σ-p53 complex and summarize some promising small molecules inhibiting the p53-MDM2 protein-protein interaction.

Elucidating Protein-protein Interactions Through Computational Approaches and Designing Small Molecule Inhibitors Against them for Various Diseases

2018 ◽  
Vol 18 (20) ◽  
pp. 1719-1736 ◽  
Author(s):  
Sharanya Sarkar ◽  
Khushboo Gulati ◽  
Manikyaprabhu Kairamkonda ◽  
Amit Mishra ◽  
Krishna Mohan Poluri
Keyword(s):  
Small Molecule ◽  
Protein Interactions ◽  
Small Molecule Inhibitors ◽  
Computational Techniques ◽  
Protein Protein Interactions ◽  
Computational Tools ◽  
Computational Approaches ◽  
Protein Protein Interaction ◽  
Wide Range ◽  
Therapeutic Measures

Background: To carry out wide range of cellular functionalities, proteins often associate with one or more proteins in a phenomenon known as Protein-Protein Interaction (PPI). Experimental and computational approaches were applied on PPIs in order to determine the interacting partners, and also to understand how an abnormality in such interactions can become the principle cause of a disease. Objective: This review aims to elucidate the case studies where PPIs involved in various human diseases have been proven or validated with computational techniques, and also to elucidate how small molecule inhibitors of PPIs have been designed computationally to act as effective therapeutic measures against certain diseases. Results: Computational techniques to predict PPIs are emerging rapidly in the modern day. They not only help in predicting new PPIs, but also generate outputs that substantiate the experimentally determined results. Moreover, computation has aided in the designing of novel inhibitor molecules disrupting the PPIs. Some of them are already being tested in the clinical trials. Conclusion: This review delineated the classification of computational tools that are essential to investigate PPIs. Furthermore, the review shed light on how indispensable computational tools have become in the field of medicine to analyze the interaction networks and to design novel inhibitors efficiently against dreadful diseases in a shorter time span.

scholarly journals Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
James O’Connell ◽  
John Porter ◽  
Boris Kroeplien ◽  
Tim Norman ◽  
Stephen Rapecki ◽  
...  
Keyword(s):  
Small Molecules ◽  
Small Molecule ◽  
Protein Interactions ◽  
General Mechanism ◽  
Protein Protein Interactions ◽  
Biologic Drugs ◽  
Small Molecule Drugs ◽  
Necrosis Factor

AbstractTumour necrosis factor (TNF) is a cytokine belonging to a family of trimeric proteins; it has been shown to be a key mediator in autoimmune diseases such as rheumatoid arthritis and Crohn’s disease. While TNF is the target of several successful biologic drugs, attempts to design small molecule therapies directed to this cytokine have not led to approved products. Here we report the discovery of potent small molecule inhibitors of TNF that stabilise an asymmetrical form of the soluble TNF trimer, compromising signalling and inhibiting the functions of TNF in vitro and in vivo. This discovery paves the way for a class of small molecule drugs capable of modulating TNF function by stabilising a naturally sampled, receptor-incompetent conformation of TNF. Furthermore, this approach may prove to be a more general mechanism for inhibiting protein–protein interactions.

scholarly journals Regulation of cadherin dimerization by chemical fragments as a trigger to inhibit cell adhesion

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Akinobu Senoo ◽  
Sho Ito ◽  
Satoru Nagatoishi ◽  
Yutaro Saito ◽  
Go Ueno ◽  
...  
Keyword(s):  
Cell Adhesion ◽  
Hydrogen Bonds ◽  
Small Molecules ◽  
Small Molecule ◽  
Protein Interactions ◽  
Therapeutic Potential ◽  
Protein Complexes ◽  
Protein Protein Interactions ◽  
Specific Chemical ◽  
Stepwise Assembly

AbstractMany cadherin family proteins are associated with diseases such as cancer. Since cell adhesion requires homodimerization of cadherin molecules, a small-molecule regulator of dimerization would have therapeutic potential. Herein, we describe identification of a P-cadherin-specific chemical fragment that inhibits P-cadherin-mediated cell adhesion. Although the identified molecule is a fragment compound, it binds to a cavity of P-cadherin that has not previously been targeted, indirectly prevents formation of hydrogen bonds necessary for formation of an intermediate called the X dimer and thus modulates the process of X dimerization. Our findings will impact on a strategy for regulation of protein-protein interactions and stepwise assembly of protein complexes using small molecules.

scholarly journals Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis

2020 ◽  
Vol 21 (4) ◽  
pp. 1334 ◽  
Author(s):  
Katarzyna A. Roszkowska ◽  
Slawomir Gizinski ◽  
Maria Sady ◽  
Zdzislaw Gajewski ◽  
Maciej B. Olszewski
Keyword(s):  
Tumor Suppressor ◽  
Protein Interactions ◽  
Molecular Mechanisms ◽  
Human Cancer ◽  
P53 Protein ◽  
Missense Mutations ◽  
Protein Protein Interactions ◽  
Gain Of Function ◽  
Suppressor Activity ◽  
Cancer Invasiveness

Forty years of research has proven beyond any doubt that p53 is a key regulator of many aspects of cellular physiology. It is best known for its tumor suppressor function, but it is also a regulator of processes important for maintenance of homeostasis and stress response. Its activity is generally antiproliferative and when the cell is damaged beyond repair or intensely stressed the p53 protein contributes to apoptosis. Given its key role in preventing cancer it is no wonder that it is the most frequently mutated gene in human cancer. Surprisingly, a subset of missense mutations occurring in p53 (gain-of-function) cause it to lose its suppressor activity and acquire new functionalities that turn the tumor suppressor protein into an oncoprotein. A solid body of evidence exists demonstrating increased malignancy of cancers with mutated p53 in all aspects considered “hallmarks of cancer”. In this review, we summarize current findings concerning the cellular processes altered by gain-of-function mutations in p53 and their influence on cancer invasiveness and metastasis. We also present the variety of molecular mechanisms regulating these processes, including microRNA, direct transcriptional regulation, protein–protein interactions, and more.

scholarly journals Targeting epigenetic protein–protein interactions with small-molecule inhibitors

2020 ◽  
Vol 12 (14) ◽  
pp. 1305-1326 ◽  
Author(s):  
Brian M Linhares ◽  
Jolanta Grembecka ◽  
Tomasz Cierpicki
Keyword(s):  
Small Molecules ◽  
Small Molecule ◽  
Protein Interactions ◽  
Small Molecule Inhibitors ◽  
Chemical Space ◽  
Scaffolding Proteins ◽  
Protein Protein Interactions ◽  
Post Translational Modifications ◽  
Inhibitor Development ◽  
Interdisciplinary Approaches

Epigenetic protein–protein interactions (PPIs) play essential roles in regulating gene expression, and their dysregulations have been implicated in many diseases. These PPIs are comprised of reader domains recognizing post-translational modifications on histone proteins, and of scaffolding proteins that maintain integrities of epigenetic complexes. Targeting PPIs have become focuses for development of small-molecule inhibitors and anticancer therapeutics. Here we summarize efforts to develop small-molecule inhibitors targeting common epigenetic PPI domains. Potent small molecules have been reported for many domains, yet small domains that recognize methylated lysine side chains on histones are challenging in inhibitor development. We posit that the development of potent inhibitors for difficult-to-prosecute epigenetic PPIs may be achieved by interdisciplinary approaches and extensive explorations of chemical space.

scholarly journals Macrocycles as protein–protein interaction inhibitors

2017 ◽  
Vol 474 (7) ◽  
pp. 1109-1125 ◽  
Author(s):  
Patrick G. Dougherty ◽  
Ziqing Qian ◽  
Dehua Pei
Keyword(s):  
Small Molecules ◽  
Protein Interactions ◽  
Cyclic Peptides ◽  
Macrocyclic Compounds ◽  
Protein Protein Interactions ◽  
Intracellular Protein ◽  
Drug Candidates ◽  
Protein Protein Interaction ◽  
The Past ◽  
Conventional Drug

Macrocyclic compounds such as cyclic peptides have emerged as a new and exciting class of drug candidates for inhibition of intracellular protein–protein interactions, which are challenging targets for conventional drug modalities (i.e. small molecules and proteins). Over the past decade, several complementary technologies have been developed to synthesize macrocycle libraries and screen them for binding to therapeutically relevant targets. Two different approaches have also been explored to increase the membrane permeability of cyclic peptides. In this review, we discuss these methods and their applications in the discovery of macrocyclic compounds against protein–protein interactions.

scholarly journals Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2–p53 Complex

2021 ◽  
Vol 22 (17) ◽  
pp. 9585
Author(s):  
Pankaj Attri ◽  
Hirofumi Kurita ◽  
Kazunori Koga ◽  
Masaharu Shiratani
Keyword(s):  
Tumor Suppressor ◽  
Protein Interactions ◽  
Structural Changes ◽  
Md Simulations ◽  
Tumor Suppressor Protein ◽  
Protein Protein Interactions ◽  
Tumor Suppressor Protein P53 ◽  
Protein P53 ◽  
Before And After ◽  
High Flexibility

The study of protein–protein interactions is of great interest. Several early studies focused on the murine double minute 2 (Mdm2)–tumor suppressor protein p53 interactions. However, the effect of plasma treatment on Mdm2 and p53 is still absent from the literature. This study investigated the structural changes in Mdm2, p53, and the Mdm2–p53 complex before and after possible plasma oxidation through molecular dynamic (MD) simulations. MD calculation revealed that the oxidized Mdm2 bounded or unbounded showed high flexibility that might increase the availability of tumor suppressor protein p53 in plasma-treated cells. This study provides insight into Mdm2 and p53 for a better understanding of plasma oncology.

scholarly journals Development of a Split Esterase for Protein-Protein Interaction Dependent Small Molecule Activation

2019 ◽  
Author(s):  
Krysten A. Jones ◽  
Kaitlin Kentala ◽  
Michael Beck ◽  
Weiwei An ◽  
Alexander Lippert ◽  
...  
Keyword(s):  
Synthetic Biology ◽  
Small Molecule ◽  
Protein Interaction ◽  
Protein Interactions ◽  
Cell Killing ◽  
Dependent Manner ◽  
Protein Protein Interactions ◽  
Protein Protein Interaction ◽  
Cytotoxic Molecule ◽  
Measured Input

Split reporters based on fluorescent proteins and luciferases have emerged as valuable tools for measuring interactions in biological systems. Relatedly, biosensors that transduce measured input signals into outputs that influence the host system are key components of engineered gene circuits for synthetic biology applications. While small molecule-based imaging agents are widely used in biological studies, and small molecule-based drugs and chemical probes can target a range of biological processes, a general method for generating a target small molecule in a biological system based on a measured input signal is lacking. Here, we develop a proximity-dependent split esterase that selectively unmasks ester-protected small molecules in an interaction-dependent manner. Exploiting the versatility of an ester-protected small molecule output, we demonstrate fluorescent, chemiluminescent, and pharmacological probe generation, each created by masking key alcohol functional groups on a target small molecule. We show the split esterase system can be used in combination with ester-masked fluorescent or luminescent probes to measure a protein-protein interactions and protein-protein interaction inhibitor engagement. We demonstrate the esterase-based reporter system is compatible with other commonly-used split reporter imaging systems for the simultaneous detection of multiple protein-protein interactions. Finally, we develop a system for selective small molecule-dependent cell killing by unmasking a cytotoxic molecule using an inducible split esterase. Presaging utility in future synthetic biology-based therapeutic applications, we also show the system can be used for intercellular cell killing via a bystander effect, where one activated cell unmasks a cytotoxic molecule and kills cells physically adjacent to the activated cells. Collectively, this work illustrates that the split esterase system is a valuable new addition to the split protein toolbox, with particularly exciting potential in synthetic biology applications.

Sign in / Sign up

Export Citation Format

Share Document